What is Narcolepsy Treatment Market?
Narcolepsy is a long-term neurological condition that causes fragmented sleep and excessive daytime sleepiness. Narcolepsy can range in severity from mild to severe. In severe cases, it can negatively impact social activities, school, work, and overall health and well-being. A person with narcolepsy may fall asleep at any time, such as while talking or driving. Symptoms tend to appear in a personís teenage years or early 20s or 30s. In the United States, it is 50% more likely to affect females than males. Experts believe that around 1 in 2,000 people have narcolepsy. Narcolepsy is a sleep disorder that features excessive daytime sleepiness.
The market study is being classified by Type (Sodium Oxybate, Antidepressants, Central Nervous System Stimulants and Others), by Application (Primary Narcolepsy with Cataplexy, Primary Narcolepsy without Cataplexy, Narcolepsy Due to Medical Conditions and Unspecified Narcolepsy) and major geographies with country level break-up.
Teva Pharmaceutical (Israel), Shire (United States), Jazz Pharmaceuticals (Ireland), Arena Pharmaceuticals (United States), Graymark Healthcare(United States) and Ligand Pharmaceuticals (United States) are some of the key players profiled in the study.
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Narcolepsy Treatment market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Narcolepsy Treatment market by Type, Application and Region.
On the basis of geography, the market of Narcolepsy Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Narcolepsy Treatment Manufacturer, Government Regulatory and Research Organizations and End-Use Industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase